Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region
TURKISH JOURNAL OF GASTROENTEROLOGY, vol.31, no.2, pp.148-155, 2020 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 31 Issue: 2
- Publication Date: 2020
- Doi Number: 10.5152/tjg.2020.19440
- Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
- Page Numbers: pp.148-155
- Karadeniz Technical University Affiliated: Yes
Abstract
Background/Aims: Hepatitis C virus (HCV) infection is a common disease that causes liver cirrhosis, hepatocellular carcinoma, and extra hepatic manifestations with high mortality and morbidity rates. This study aimed to present real-life experiences and results of treatment of HCV infection with direct-acting antiviral agents (DAAs) from the Euro-Asian region, including Turkey and Azerbaijan.